The center for devices and radiological health (cdrh) of the food and drug administration (fda) has completed its review of your premarket approval application (pma) supplement for the pd-l1 ihc 22c3 pharmdx for expanding the indications to include detection of pd-l1 protein in patients with triple-negative breast cancer (tnbc) for treatment with keytruda. We are pleased to inform you that the pma supplement is approved. You may begin commercial distribution of the device in accordance with the conditions of approval described.
Device | PD-L1 IHC 22C3 pharmDX |
Generic Name | Immunohistochemistry Assay, Antibody, Programmed Death-ligand 1 |
Applicant | DAKO NORTH AMERICA, INC. |
Date Received | 2020-06-29 |
Decision Date | 2020-11-13 |
PMA | P150013 |
Supplement | S020 |
Product Code | PLS |
Advisory Committee | Pathology |
Supplement Type | Panel Track |
Supplement Reason | Labeling Change - Indications/instructions/shelf Life/tradename |
Expedited Review | No |
Combination Product | No |
Applicant Address | DAKO NORTH AMERICA, INC. 6392 Via Real carpinteria, CA 93013 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P150013 | | Original Filing |
S025 |
2022-08-08 |
Real-time Process |
S024 |
2022-01-31 |
Special (immediate Track) |
S023 |
2021-11-17 |
Special (immediate Track) |
S022 | | |
S021 |
2020-08-31 |
Normal 180 Day Track |
S020 |
2020-06-29 |
Panel Track |
S019 |
2020-02-06 |
Normal 180 Day Track No User Fee |
S018 |
2019-09-05 |
Normal 180 Day Track No User Fee |
S017 |
2019-06-14 |
Normal 180 Day Track |
S016 |
2019-02-25 |
Panel Track |
S015 |
2019-02-15 |
30-day Notice |
S014 | | |
S013 |
2018-12-21 |
30-day Notice |
S012 | | |
S011 |
2018-06-25 |
Panel Track |
S010 |
2018-03-12 |
30-day Notice |
S009 |
2018-01-29 |
Panel Track |
S008 |
2017-12-26 |
30-day Notice |
S007 |
2017-09-21 |
Normal 180 Day Track No User Fee |
S006 |
2017-04-19 |
Panel Track |
S005 |
2017-04-17 |
30-day Notice |
S004 |
2016-12-27 |
Real-time Process |
S003 |
2016-08-19 |
Real-time Process |
S002 |
2016-06-28 |
Real-time Process |
S001 |
2015-12-31 |
Panel Track |
NIH GUDID Devices